Marc Maliepaard - Concepedia

Author

Marc Maliepaard

The Netherlands Cancer Institute

Also Known As

M Maliepaard, M. Maliepaard, MARC MALIEPAARD, Marc Maliepaard

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Utrecht University Rotterdam University of Applied Sciences Oncode Institute University of Amsterdam

About

Marc Maliepaard is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	2.6K
2	Cell Biology	9	9	2.4K
3	Biochemistry	3	3	148
4	Natural Sciences	2	2	89
5	Cellular Physiology	1	1	1.1K

Marc Maliepaard

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Marc Maliepaard, George L. Scheffer, Ian F. Faneyte, PubMed Breast OncologyImmunologySubcellular LocalizationImmunotherapyCellular Physiology	2001	1.1K
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Marc Maliepaard, M A van Gastelen, L A de Jong, PubMed Chemoprevention StrategyPathologyCancer BiologyTumor BiologyOvarian Cancer	1999	487
Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material Julio E. Diestra, George L. Scheffer, Isabel Català, The Journal of Pathology	2002	273
Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918. Marc Maliepaard, Margôt A. van Gastelen, Akiko Tohgo, PubMed Breast OncologyChemoprevention StrategyBcrp-mediated ResistanceTumor BiologyOvarian Cancer	2001	234
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren, PubMed Tumor BiologyBreast OncologyOncologyCi1033 AccumulationGlioma	2001	222
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. G L Scheffer, Marc Maliepaard, A C Pijnenborg, PubMed Breast OncologyImmunologyPathologyTumor CellsImmunotherapy	2000	170
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin Jetske M. Meerum Terwogt, Gerard Groenewegen, Dick Pluim, Cancer Chemotherapy and Pharmacology Lipid PreparationPharmaceutical SciencePharmacokinetic StudyPharmacologyRadiation Oncology	2002	122
Expression of the breast cancer resistance protein in breast cancer. Ian F. Faneyte, Petra Kristel, Marc Maliepaard, PubMed	2002	118
Transport of Topoisomerase I Inhibitors by the Breast Cancer Resistance Protein: Potential Clinical Implications J. Schellens, Marc Maliepaard, Rik J. Scheper, Annals of the New York Academy of Sciences	2000	112
Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia Jean Sargent, Christine Williamson, Marc Maliepaard, British Journal of Haematology	2001	92

Page 1